RSV season kicks off: Clinicians warned about potential surges in paediatric cases
With the RSV season officially underway in South Africa, experts are urging healthcare providers to prepare for an influx of ...
McKnight's Long-Term Care News1d
Older adults more apt to receive RSV vaccine, but uptake low in long-term care: study
Older adults and people with certain medical conditions are more likely to receive the respiratory syncytial virus (RSV) ...
Mirage News2d
Beyfortus Launch: Major RSV Shield for Babies This Winter
Largest childhood preventative health initiative in nearly 20 yearsBeyfortus rollout to ensure all babies are RSV protected this winterThe largest ...
Bizcommunity on MSN2h
When it’s not flu…
While the ‘official’ flu season may still be a month or two away, reports indicate a rise in respiratory illnesses like the ...
European Commission approves Pfizer's RSV vaccine for adults at increased risk of disease
The European Commission approved Pfizer's respiratory syncytial virus vaccine for the prevention of lower respiratory tract ...
Immunization program for babies slashes RSV hospital admissions
An Australian-first study demonstrating the effectiveness of a new immunization against respiratory syncytial virus (RSV) for ...
Is the ‘quad-demic’ over? UNC hospitals are making some changes. Here’s what to know
COVID, flu and RSV levels have already hit their peaks. (Pollen levels and springtime allergies are a whole different story.) ...
Mirage News20h
Babies Protected From RSV
The Malinauskas Labor Government is keeping South Australian babies safe from Respiratory Syncytial Virus (RSV) this winter, with a long-acting ...
CIDRAP6h
RSV vaccine uptake in adults tied to older age, pulmonary disease
The authors assessed the patient characteristics associated with RSV vaccination among older adults hospitalized during the ...
When you have a cold, is it worth taking a rapid antigen test to find out if it is flu, COVID or RSV?
In recent years, the familiar symptoms of the flu might kick us into reaching for at-home testing kits. But on the eve of the ...
Pharmabiz22h
Pfizer’s RSV vaccine Abrysvo receives European approval to help protect adults aged 18-59 against RSV lower respiratory tract disease
Pfizer’s RSV vaccine Abrysvo receives European approval to help protect adults aged 18-59 against RSV lower respiratory tract disease: New York Wednesday, April 2, 2025, 09:00 H ...